CATX$0.9403-9.59%
Perspective Therapeutics, Inc.
Sector: Pharmaceutical PreparationsIndustry: Medical - DevicesCountry: USExchange: NYSE
Mkt Cap:$107.34M
Float & O/S:
Inst Own:
DilutionScan read 47 of Perspective Therapeutics, Inc.'s SEC filings and found 5 warrant series, 1 convertible, 2 ATM programs, 3 shelf registrations and 1 completed offering on file for CATX. The latest dilution event on file is ATM sales on Mar 12, 2026. Analysis updated Oct 31, 2026.
